# BGI Genomics

China's genomics powerhouse — CRISPR-based diagnostics kits, DNBSEQ sequencing for pathogen identification, and large-scale COVID diagnostics infrastructure deployed in 80+ countries.

Source: https://en.bioecon.ru/companies/bgi/
Updated: 2026-06-19

- Country: China
- Revenue: CNY 3B
- Employees: ~10,000 emp

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $80 million USD raised in IPO (2017-07-17) | https://www.fiercebiotech.com/medtech/chinese-sequencing-giant-bgi-genomics-raises-80m-ipo |
| Headquarters | Shenzhen, Guangdong Province, China (2026-08-31) | https://www.bgi.com/global |
| Revenue | 3.705 billion CNY (3,705,385,018.37 CNY) for 2025 fiscal year (2025-12-31) | https://static.cninfo.com.cn/finalpage/2026-08-22/1225492096.PDF |
| Production site | Addis Ababa, Ethiopia (COVID-19 testing kit production factory) (2020-09-30) | https://en.genomics.cn/history.html |
| Capacity | Ethiopia factory annual output of 10 million COVID-19 testing kits (2022-12-31) | https://en.genomics.cn/2022bgigroupmilestones/, https://en.genomics.cn/history.html |
| Certification | EU CE certification for monkeypox nucleic acid detection kit and COVID-19 antigen detection kit (colloidal gold method) (2022-12-31) | https://en.genomics.cn/2022bgigroupmilestones/, https://en.genomics.cn/history.html |
| Regulatory approval | Emergency approval from China NMPA for COVID-19 detection kits and DNBSEQ-T7 sequencing system (2020-01-26) | https://en.genomics.cn/en-news-5636.html, https://en.genomics.cn/history.html |

Independent sources: bgi.com, en.genomics.cn, fiercebiotech.com, static.cninfo.com.cn

## Technologies

- [Biodiversity credits](https://en.bioecon.ru/technology/biodiversity-credits/)
- [Biodiversity genomics](https://en.bioecon.ru/technology/biodiversity-genomics/)
- [Bioinformatics & multi-omics](https://en.bioecon.ru/technology/bioinformatics-multi-omics/)
- [Biological authentication & identification](https://en.bioecon.ru/technology/biological-authentication-identification/)
- [CRISPR diagnostics](https://en.bioecon.ru/technology/crispr-diagnostics/)
- [De-extinction & conservation biotech](https://en.bioecon.ru/technology/de-extinction-conservation-biotech/)
- [Diagnostics & biosensors](https://en.bioecon.ru/technology/diagnostics-biosensors/)
- [DNA synthesis & gene foundry](https://en.bioecon.ru/technology/dna-synthesis-gene-foundry/)
- [DTC genetic testing](https://en.bioecon.ru/technology/dtc-genetic-testing/)
- [FemTech biotech & women's health](https://en.bioecon.ru/technology/femtech-biotech-womens-health/)
- [Forest & agroecosystem biomonitoring (smart)](https://en.bioecon.ru/technology/forest-agroecosystem-biomonitoring/)
- [Genomic pathogen surveillance (service)](https://en.bioecon.ru/technology/genomic-pathogen-surveillance/)
- [Invasive-species biomonitoring via eDNA](https://en.bioecon.ru/technology/edna-invasive-species-biomonitoring/)
- [Personalized diagnostics](https://en.bioecon.ru/technology/personalized-diagnostics/)
- [Personalized nutrition](https://en.bioecon.ru/technology/personalized-nutrition/)
- [Single-cell omics](https://en.bioecon.ru/technology/single-cell-omics/)
- [Sovereign genome databases (plants, animals, microbes)](https://en.bioecon.ru/technology/sovereign-genome-databases/)
- [Spatial transcriptomics & spatial multi-omics](https://en.bioecon.ru/technology/spatial-transcriptomics-spatial-multi-omics/)